SEC ownership of MAXCYTE, INC.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001287098.

Comparable stake leader

Capricorn Fund Managers Ltd

Disclosed value leader

Capricorn Fund Managers Ltd

Comparable rows

50/50

Latest evidence

31 Mar 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Capricorn Fund Managers Ltd
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
31 Mar 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001287098
Issuer location
Rockville, MD

Ownership snapshot

Top shareholders of MAXCYTE, INC. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Capricorn Fund Managers Ltd
Disclosed value leader
Capricorn Fund Managers Ltd
Comparable rows
50/50
Latest evidence
31 Mar 2026
13D/G 13F 3/4/5 Lead comparable stake: 7.7% 13D/G row: Capricorn Fund Managers Ltd Showing 1-8 of 50 holder rows.

Quick read

Capricorn Fund Managers Ltd leads the comparable SEC ownership view at 7.7%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Capricorn Fund Managers Ltd's linked filing trail.
Comparable ownership Top 5
Capricorn Fund Managers Ltd 7.7%
BlackRock, Inc. 6.6%
RIVER GLOBAL INVESTORS LLP 5.2%
CADIAN CAPITAL MANAGEMENT, LP 3.5%
Douglas J. Swirsky 0.14%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Capricorn Fund Managers Ltd
13D/G 13F
Company
7.7%
$12,710,000
8,200,000 shares
$0 30 Jan 2026
BlackRock, Inc.
13D/G 13F
Company
6.6%
$10,845,655
6,997,197 shares
-$1,951,145 31 Dec 2025
RIVER GLOBAL INVESTORS LLP
13D/G
5.2%
$8,685,974
5,497,452 shares
$0 23 Sep 2025
CADIAN CAPITAL MANAGEMENT, LP
13D/G 13F
Company
3.5%
$5,708,731
3,683,052 shares
-$7,044,054 31 Dec 2025
Douglas J. Swirsky
3/4/5
CHIEF FINANCIAL OFFICER
0.14%
$123,610
151,669 shares
+$56,234 17 Mar 2026
Vitruvian Partners LLP
13F
Company
13F
4.8%
$3,542,958
5,043,356 shares
31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
3.8%
$2,799,217
3,981,816 shares
31 Mar 2026
MORGAN STANLEY
13F
Company
13F
3.5%
$2,590,912
3,688,131 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$471,909.

Buys
$480,175
Insiders: 5
Sells
$8,266
Insiders: 1
Net
+$471,909
Shares: +344,858
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 355,000 Shares: 10,142
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 10,142 $0 $8,266 -$8,266
6-9 0 0 $0 $0 $0
9-12 355,000 0 $480,175 $0 +$480,175

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 21 reporting-owner rows connected to MAXCYTE, INC.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
21
Largest Forms 3/4/5 holder
Casdin Partners Master Fund, L.P.
Net 12M change
+$471,909
Latest report
17 Jun 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Casdin Partners Master Fund, L.P. 10%+ Owner $45,300,000 Mixed 03 Oct 2022
Art Mandell Director $1,940,066 Mixed 11 Jun 2024
Douglas Doerfler President and CEO, Director $1,509,382 Mixed 04 Dec 2023
Maher Masoud President and CEO, Director $736,250 +$102,915 +16% Mixed 27 Mar 2026
J. Stark Thompson PhD Director $502,459 Mixed 09 Aug 2021
Stanley C. Erck Director $301,196 +$137,220 +84% Mixed 17 Jun 2026
David I. Sandoval General Counsel $204,171 Filing P/S 18 Mar 2025
Ali Soleymannezhad Chief Commercial Officer $188,974 Filing P/S 18 Mar 2025
DOUGLAS RICHARD Director $183,351 +$111,040 +154% Mixed 17 Jun 2026
John Joseph Johnston Director $141,610 Mixed 17 Jun 2026
Parmeet Ahuja Chief Financial Officer $131,812 Mixed 15 Apr 2026
William W. Brooke Director $127,363 +$64,500 +103% Mixed 17 Jun 2026
Douglas J. Swirsky Chief Financial Officer $123,610 +$56,234 +83% Filing P/S 17 Mar 2026
Thomas M. Ross Evp, Global Sales $109,025 Filing P/S 01 Aug 2024
Cynthia Collins Director $78,195 Mixed 17 Jun 2026
B. al Wakeel Director $56,901 Mixed 17 Jun 2026
Patrick J. Balthrop Director $56,901 Mixed 17 Jun 2026
Rekha Hemrajani Director $49,395 Mixed 17 Jun 2026
Cenk Sumen Chief Scientific Officer Mixed 11 Apr 2022
Amanda Louise Murphy Chief Financial Officer Mixed 25 Mar 2022

Recent insider transactions for MAXCYTE, INC.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
John Joseph Johnston MXCT Common Stock Award 17.8% 30,421 201,581 17 Jun 2026 Direct
John Joseph Johnston MXCT Stock Option (right to buy) Award 49,579 49,579 17 Jun 2026 Direct
Rekha Hemrajani MXCT Common Stock Award 76.3% 30,421 70,314 17 Jun 2026 Direct
Rekha Hemrajani MXCT Stock Option (right to buy) Award 49,579 49,579 17 Jun 2026 Direct
Stanley C. Erck MXCT Common Stock Award 7.64% 30,421 428,749 17 Jun 2026 Direct
Stanley C. Erck MXCT Stock Option (right to buy) Award 49,579 49,579 17 Jun 2026 Direct
Douglas Richard MXCT Common Stock Award 13.2% 30,421 260,998 17 Jun 2026 Direct
Douglas Richard MXCT Stock Option (right to buy) Award 49,579 49,579 17 Jun 2026 Direct
Cynthia Collins MXCT Common Stock Award 37.6% 30,421 111,310 17 Jun 2026 Direct
Cynthia Collins MXCT Stock Option (right to buy) Award 49,579 49,579 17 Jun 2026 Direct
William W. Brooke MXCT Common Stock Award 20.2% 30,421 181,300 17 Jun 2026 Direct
William W. Brooke MXCT Stock Option (right to buy) Award 49,579 49,579 17 Jun 2026 Direct
Patrick J. Balthrop MXCT Common Stock Award 60.2% 30,421 80,998 17 Jun 2026 Direct
Patrick J. Balthrop MXCT Stock Option (right to buy) Award 49,579 49,579 17 Jun 2026 Direct
B. al Wakeel MXCT Common Stock Award 60.2% 30,421 80,998 17 Jun 2026 Direct
B. al Wakeel MXCT Stock Option (right to buy) Award 49,579 49,579 17 Jun 2026 Direct
Parmeet Ahuja MXCT Common Stock Award 187,500 187,500 15 Apr 2026 Direct
Parmeet Ahuja MXCT Employee Stock Option (right to buy) Award 375,000 375,000 30 Mar 2026 Direct
Maher Masoud MXCT Common Stock Award 171.4% 300,000 475,000 27 Mar 2026 Direct
Maher Masoud MXCT Employee Stock Option (right to buy) Award 600,000 600,000 27 Mar 2026 Direct
Douglas J. Swirsky MXCT Common Stock Sale -6.27% $8,266 $0.8150 -10,142 151,669 17 Mar 2026 Direct
Douglas J. Swirsky MXCT Common Stock Purchase 44.7% $64,500 $1.29 50,000 161,811 13 Aug 2025 Direct
Maher Masoud MXCT Common Stock Purchase 75% $102,915 $1.37 75,000 175,000 13 Aug 2025 Direct
Stanley C. Erck MXCT Common Stock Purchase 33.5% $137,220 $1.37 100,000 398,328 13 Aug 2025 Direct
Douglas Richard MXCT Common Stock Purchase 53.1% $111,040 $1.39 80,000 230,577 13 Aug 2025 Direct
William W. Brooke MXCT Common Stock Purchase 49.6% $64,500 $1.29 50,000 150,879 13 Aug 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .